Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer.

Journal of gynecologic oncology - 1 Nov 2024

Baek Min-Hyun, Chen Lei, Tekin Cumhur, Cristescu Razvan, Jin Xiao Yang, Shao Changxia, Ihm Soo Yeon, Jelinic Petar, Park Jeong-Yeol

Abstract excerpt

OBJECTIVE: To evaluate the prevalence and prognostic role of programmed death ligand 1 (PD-L1) expression and tumor mutational burden (TMB) in patients with non-immunotherapy-treated advanced cervical cancer. METHODS: Clinical data were retrospectively collected from medical records between January 1, 2008, and December 31, 2016, at Asan Medical Center (Korea); archived tumor samples were assessed for PD-L1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to B7-H1 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Carcinoma, Adenosquamous

Share to Carcinoma, Squamous Cell

Share to Neoplasm Recurrence, Local

Share to Prevalence

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 38857910
DOI: 10.3802/jgo.2024.35.e105
PMCID: PMC11543264

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer.PMID 38857910Read ↗

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.Semantic proximity Read ↗

Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.Semantic proximity Read ↗

The interplay between programmed death ligand 1 (PD-L1) expression and human papillomavirus (HPV) genotypes in cervical carcinomas: findings of a Nigerian Tertiary Hospital.Semantic proximity Read ↗

Genomic landscape, immune characteristics and a prognostic mutation signature of cervical cancer in ChinaSemantic proximity Read ↗

A comprehensive pan-cancer analysis of CD274 gene amplification, tumor mutation burden, microsatellite instability, and PD-L1 expression in Chinese cancer patientsSemantic proximity Read ↗

Polo like kinase 1 expression in cervical cancer tissues generated from multiple detection methodsSemantic proximity Read ↗

Trends in Cervical Cancer Incidence and Mortality in the United States, 1975-2018. A Population-Based StudySemantic proximity Read ↗

Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significanceSemantic proximity Read ↗

Integrated genomic and molecular characterization of cervical cancer.Semantic proximity Read ↗

Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.Semantic proximity Read ↗

Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression.Semantic proximity Read ↗

The frequency and inter-relationship of PD-L1 expression and tumour mutational burden across multiple types of advanced solid tumours in ChinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.